-
Something wrong with this record ?
Microtubule disruptors and their interaction with biotransformation enzymes
M. Modrianský, Z. Dvorák
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
16601758
DOI
10.5507/bp.2005.028
Knihovny.cz E-resources
- MeSH
- Antimitotic Agents pharmacology MeSH
- Biotransformation MeSH
- Colchicine pharmacology MeSH
- Drug Interactions MeSH
- Humans MeSH
- Microtubules drug effects MeSH
- Nocodazole pharmacology MeSH
- Paclitaxel pharmacology MeSH
- Receptors, Aryl Hydrocarbon metabolism MeSH
- Receptors, Glucocorticoid metabolism MeSH
- Signal Transduction MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Vinblastine pharmacology MeSH
- Vincristine pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Microtubule disruptors, widely known as antimitotics, have broad applications in human medicine, especially as anti-neoplastic agents. They are subject to biotransformation within human body frequently involving cytochromes P450. Therefore antimitotics are potential culprits of drug-drug interactions on the level of activity as well as expression of cytochromes P450. This review discusses the effects of four well-known natural antimitotics: colchicine, taxol (paclitaxel), vincristine, and vinblastine, and a synthetic microtubule disruptor nocodazole on transcriptional activity of glucocorticoid and aryl hydrocarbon receptors. It appears that microtubules disarray restricts the signaling by these two nuclear receptors regardless of cell cycle phase. Consequently, intact microtubules play an important role in the regulation of expression of cytochromes P450, which are under direct or indirect control of the two nuclear receptors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003770
- 003
- CZ-PrNML
- 005
- 20130228111408.0
- 007
- ta
- 008
- 130128s2005 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2005.028 $2 doi
- 035 __
- $a (PubMed)16601758
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Modrianský, Martin, $d 1966- $7 xx0042117 $u Institute of Medical Chemistry and Biochemistry, Palacký University, Olomouc
- 245 10
- $a Microtubule disruptors and their interaction with biotransformation enzymes / $c M. Modrianský, Z. Dvorák
- 520 9_
- $a Microtubule disruptors, widely known as antimitotics, have broad applications in human medicine, especially as anti-neoplastic agents. They are subject to biotransformation within human body frequently involving cytochromes P450. Therefore antimitotics are potential culprits of drug-drug interactions on the level of activity as well as expression of cytochromes P450. This review discusses the effects of four well-known natural antimitotics: colchicine, taxol (paclitaxel), vincristine, and vinblastine, and a synthetic microtubule disruptor nocodazole on transcriptional activity of glucocorticoid and aryl hydrocarbon receptors. It appears that microtubules disarray restricts the signaling by these two nuclear receptors regardless of cell cycle phase. Consequently, intact microtubules play an important role in the regulation of expression of cytochromes P450, which are under direct or indirect control of the two nuclear receptors.
- 650 _2
- $a antimitotika $x farmakologie $7 D050256
- 650 _2
- $a biotransformace $7 D001711
- 650 _2
- $a kolchicin $x farmakologie $7 D003078
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a lékové interakce $7 D004347
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrotubuly $x účinky léků $7 D008870
- 650 _2
- $a nokodazol $x farmakologie $7 D015739
- 650 _2
- $a paclitaxel $x farmakologie $7 D017239
- 650 _2
- $a receptory aromatických uhlovodíků $x metabolismus $7 D018336
- 650 _2
- $a receptory glukokortikoidů $x metabolismus $7 D011965
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a vinblastin $x farmakologie $7 D014747
- 650 _2
- $a vinkristin $x farmakologie $7 D014750
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Dvořák, Zdeněk, $d 1974- $7 xx0118950 $u Institute of Medical Chemistry and Biochemistry, Palacký University, Olomouc
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 149, č. 2 (2005), s. 213-215
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130228111608 $b ABA008
- 999 __
- $a ok $b bmc $g 966424 $s 801965
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2005 $b 149 $c 2 $d 213-215 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128